Elevated expression level of CD56 (neural cell adhesion molecule; NCAM1) has been detected in a range of cancers and it is associated with the diagnosis or prognosis of small cell lung cancer [52], as well as Merkel cell-carcinoma [53] and ovarian cancer [54]. Here, CHL1 is linked to small cell lung carcinoma.